CVC Capital Partners and Turkven Private Equity may acquire stake in Bilim Pharmaceuticals - MarketLine Financial Deals

CVC Capital Partners and Turkven Private Equity may acquire stake in Bilim Pharmaceuticals

CVC Capital Partners and Turkven Private Equity may acquire stake in Bilim Pharmaceuticals - MarketLine Financial Deals
CVC Capital Partners and Turkven Private Equity may acquire stake in Bilim Pharmaceuticals
Published Apr 08, 2011
3 pages — Published Apr 08, 2011
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

According to Reuters, CVC Capital Partners GroupSICAV-FIS S.A. is working with Turkven Private Equity to acquire a stake in Bilim Pharmaceuticals, a Turkey-based generic drugs manufacturing company.

  
Source:
Document ID
MA58138_110413
Country
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "CVC Capital Partners and Turkven Private Equity may acquire stake in Bilim Pharmaceuticals" Apr 08, 2011. Alacra Store. Dec 04, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/CVC-Capital-Partners-and-Turkven-Private-Equity-may-acquire-stake-in-Bilim-Pharmaceuticals-2052-59179>
  
APA:
MarketLine Financial Deals. (2011). CVC Capital Partners and Turkven Private Equity may acquire stake in Bilim Pharmaceuticals Apr 08, 2011. New York, NY: Alacra Store. Retrieved Dec 04, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/CVC-Capital-Partners-and-Turkven-Private-Equity-may-acquire-stake-in-Bilim-Pharmaceuticals-2052-59179>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.